A framework for the investigation of rare genetic disorders in neuropsychiatry

De novo and inherited rare genetic disorders (RGDs) are a major cause of human morbidity, frequently involving neuropsychiatric symptoms. Recent advances in genomic technologies and data sharing have revolutionized the identification and diagnosis of RGDs, presenting an opportunity to elucidate the...

Full description

Bibliographic Details
Main Authors: Sanders, Stephan J. (Author), Sahin, Mustafa (Author), Hostyk, Joseph (Author), Thurm, Audrey (Author), Jacquemont, Sebastien (Author), Avillach, Paul (Author), Douard, Elise (Author), Martin, Christa L. (Author), Modi, Meera E. (Author), Moreno- (Author), Raznahan, Armin (Author), Anticevic, Alan (Author), Dolmetsch, Ricardo (Author), Feng, Guoping (Author), Geschwind, Daniel H. (Author), Glahn, David C. (Author), Goldstein, David B. (Author), Ledbetter, David H. (Author), Mulle, Jennifer G. (Author), Pasca, Sergiu P. (Author), Samaco, Rodney (Author), Sebat, Jonathan (Author), Pariser, Anne (Author), Lehner, Thomas (Author), Gur, Raquel E. (Author), Bearden, Carrie E. (Author)
Other Authors: McGovern Institute for Brain Research at MIT (Contributor), Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences (Contributor)
Format: Article
Language:English
Published: Springer Science and Business Media LLC, 2021-04-23T16:04:33Z.
Subjects:
Online Access:Get fulltext
LEADER 02618 am a22004693u 4500
001 130514
042 |a dc 
100 1 0 |a Sanders, Stephan J.  |e author 
100 1 0 |a McGovern Institute for Brain Research at MIT  |e contributor 
100 1 0 |a Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences  |e contributor 
700 1 0 |a Sahin, Mustafa  |e author 
700 1 0 |a Hostyk, Joseph  |e author 
700 1 0 |a Thurm, Audrey  |e author 
700 1 0 |a Jacquemont, Sebastien  |e author 
700 1 0 |a Avillach, Paul  |e author 
700 1 0 |a Douard, Elise  |e author 
700 1 0 |a Martin, Christa L.  |e author 
700 1 0 |a Modi, Meera E.  |e author 
700 1 0 |a Moreno-  |e author 
700 1 0 |a Raznahan, Armin  |e author 
700 1 0 |a Anticevic, Alan  |e author 
700 1 0 |a Dolmetsch, Ricardo  |e author 
700 1 0 |a Feng, Guoping  |e author 
700 1 0 |a Geschwind, Daniel H.  |e author 
700 1 0 |a Glahn, David C.  |e author 
700 1 0 |a Goldstein, David B.  |e author 
700 1 0 |a Ledbetter, David H.  |e author 
700 1 0 |a Mulle, Jennifer G.  |e author 
700 1 0 |a Pasca, Sergiu P.  |e author 
700 1 0 |a Samaco, Rodney  |e author 
700 1 0 |a Sebat, Jonathan  |e author 
700 1 0 |a Pariser, Anne  |e author 
700 1 0 |a Lehner, Thomas  |e author 
700 1 0 |a Gur, Raquel E.  |e author 
700 1 0 |a Bearden, Carrie E.  |e author 
245 0 0 |a A framework for the investigation of rare genetic disorders in neuropsychiatry 
260 |b Springer Science and Business Media LLC,   |c 2021-04-23T16:04:33Z. 
856 |z Get fulltext  |u https://hdl.handle.net/1721.1/130514 
520 |a De novo and inherited rare genetic disorders (RGDs) are a major cause of human morbidity, frequently involving neuropsychiatric symptoms. Recent advances in genomic technologies and data sharing have revolutionized the identification and diagnosis of RGDs, presenting an opportunity to elucidate the mechanisms underlying neuropsychiatric disorders by investigating the pathophysiology of high-penetrance genetic risk factors. Here we seek out the best path forward for achieving these goals. We think future research will require consistent approaches across multiple RGDs and developmental stages, involving both the characterization of shared neuropsychiatric dimensions in humans and the identification of neurobiological commonalities in model systems. A coordinated and concerted effort across patients, families, researchers, clinicians and institutions, including rapid and broad sharing of data, is now needed to translate these discoveries into urgently needed therapies. 
546 |a en 
655 7 |a Article 
773 |t Nature Medicine